Indication

Klebsiella pneumonia

Klebsiella pneumonia is an acute lower respiratory tract infection caused by the Gram-negative, encapsulated bacterium *Klebsiella pneumoniae*. Read more about Klebsiella pneumonia

346 drugs 124 manufacturers

Advertisement

Drugs that treat it

Common Klebsiella pneumonia therapies.

Showing 55–63 of 346 drugs

Filter & compare in the drug finder →Opens the drug finder with Klebsiella pneumonia preselected.

News & literature

Coming soon

Related codes

Coming soon
Coming soon

About Klebsiella pneumonia.

Klebsiella pneumonia is an acute lower respiratory tract infection caused by the Gram-negative, encapsulated bacterium *Klebsiella pneumoniae*.

It predominantly affects the pulmonary parenchyma and alveolar spaces, most commonly occurring as a hospital-acquired infection in hospitalized or mechanically ventilated patients, but also presenting in individuals with underlying comorbidities such as alcohol use disorder, chronic lung disease, or diabetes mellitus.

Pathophysiologically, the organism's thick polysaccharide capsule impairs phagocytosis, frequently leading to severe necrotizing inflammation, microabscess formation, lung cavitation, and characteristic production of thick, blood-tinged "currant jelly" sputum.

Clinically, it manifests with high fevers, productive cough, pleuritic chest pain, and dyspnea, carrying a substantial risk of rapid progression to bacteremia, respiratory failure, and sepsis.

Personalize your experience

Follow Klebsiella pneumonia and get updates as they land.

Create a free account

Follow an indication and get alerts when its drugs, labels, or guidelines change

Save any drug on this page to your favorites, synced across devices

AI-curated peer-reviewed research, summarized for your specialty

A morning digest of indication-relevant updates, when you want it